---
document_datetime: 2023-10-31 11:06:18
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/tandemact-epar-all-authorised-presentations_en.pdf
document_name: tandemact-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7072723
conversion_datetime: 2025-12-23 00:37:46.52206
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU number       | Invented name   | Strength   | Pharmaceutical Form   | Route of Administration   | Packaging         |   Package size |
|-----------------|-----------------|------------|-----------------------|---------------------------|-------------------|----------------|
| EU/1/06/366/006 | Tandemact       | 30 mg/4 mg | Tablet                | Oral use                  | blister (alu/alu) |             28 |
| EU/1/06/366/018 | Tandemact       | 30 mg/2 mg | Tablet                | Oral use                  | blister (alu/alu) |             28 |